Annual EBITDA
-$29.89 M
+$21.76 M+42.13%
December 31, 2024
Summary
- As of March 8, 2025, IMCR annual EBITDA is -$29.89 million, with the most recent change of +$21.76 million (+42.13%) on December 31, 2024.
- During the last 3 years, IMCR annual EBITDA has risen by +$136.83 million (+82.07%).
- IMCR annual EBITDA is now at all-time high.
Performance
IMCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$15.27 M
-$26.18 M-240.04%
December 31, 2024
Summary
- As of March 8, 2025, IMCR quarterly EBITDA is -$15.27 million, with the most recent change of -$26.18 million (-240.04%) on December 31, 2024.
- Over the past year, IMCR quarterly EBITDA has stayed the same.
- IMCR quarterly EBITDA is now -240.04% below its all-time high of $10.91 million, reached on September 30, 2024.
Performance
IMCR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$29.57 M
+$8.03 M+21.35%
December 31, 2024
Summary
- As of March 8, 2025, IMCR TTM EBITDA is -$29.57 million, with the most recent change of +$8.03 million (+21.35%) on December 31, 2024.
- Over the past year, IMCR TTM EBITDA has stayed the same.
- IMCR TTM EBITDA is now at all-time high.
Performance
IMCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IMCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.1% | 0.0% | 0.0% |
| 3 y3 years | +82.1% | +64.6% | +82.5% |
| 5 y5 years | +79.9% | +61.1% | +80.8% |
IMCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.1% | -240.0% | +64.6% | at high | +82.5% |
| 5 y | 5-year | at high | +82.1% | -240.0% | +66.3% | at high | +82.5% |
| alltime | all time | at high | +82.1% | -240.0% | +66.3% | at high | +82.5% |
Immunocore Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$29.89 M(-42.1%) | -$15.27 M(-240.0%) | -$29.57 M(-21.3%) |
| Sep 2024 | - | $10.91 M(-303.0%) | -$37.60 M(-17.1%) |
| Jun 2024 | - | -$5.37 M(-72.9%) | -$45.37 M(-16.8%) |
| Mar 2024 | - | -$19.83 M(-14.9%) | -$54.52 M(+5.6%) |
| Dec 2023 | -$51.65 M(+71.4%) | -$23.30 M(-844.6%) | -$51.65 M(+13.9%) |
| Sep 2023 | - | $3.13 M(-121.5%) | -$45.33 M(+14.6%) |
| Jun 2023 | - | -$14.52 M(-14.4%) | -$39.57 M(+25.3%) |
| Mar 2023 | - | -$16.95 M(-0.2%) | -$31.57 M(-7.2%) |
| Dec 2022 | -$30.14 M | -$16.99 M(-291.1%) | -$34.02 M(-43.5%) |
| Sep 2022 | - | $8.89 M(-236.3%) | -$60.23 M(-44.4%) |
| Jun 2022 | - | -$6.52 M(-66.4%) | -$108.36 M(-26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$19.40 M(-55.1%) | -$147.10 M(-13.0%) |
| Dec 2021 | -$166.72 M(+62.5%) | -$43.20 M(+10.1%) | -$169.00 M(+9.8%) |
| Sep 2021 | - | -$39.24 M(-13.3%) | -$153.95 M(+8.7%) |
| Jun 2021 | - | -$45.26 M(+9.6%) | -$141.60 M(+19.5%) |
| Mar 2021 | - | -$41.31 M(+46.8%) | -$118.52 M(+18.0%) |
| Dec 2020 | -$102.59 M(-30.9%) | -$28.14 M(+4.6%) | -$100.42 M(-12.6%) |
| Sep 2020 | - | -$26.89 M(+21.2%) | -$114.85 M(+30.6%) |
| Jun 2020 | - | -$22.19 M(-4.4%) | -$87.96 M(+33.7%) |
| Mar 2020 | - | -$23.21 M(-45.5%) | -$65.77 M(+54.5%) |
| Dec 2019 | -$148.40 M(+45.0%) | -$42.57 M | -$42.57 M |
| Dec 2018 | -$102.31 M | - | - |
FAQ
- What is Immunocore Holdings annual EBITDA?
- What is the all time high annual EBITDA for Immunocore Holdings?
- What is Immunocore Holdings annual EBITDA year-on-year change?
- What is Immunocore Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Immunocore Holdings?
- What is Immunocore Holdings quarterly EBITDA year-on-year change?
- What is Immunocore Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Immunocore Holdings?
- What is Immunocore Holdings TTM EBITDA year-on-year change?
What is Immunocore Holdings annual EBITDA?
The current annual EBITDA of IMCR is -$29.89 M
What is the all time high annual EBITDA for Immunocore Holdings?
Immunocore Holdings all-time high annual EBITDA is -$29.89 M
What is Immunocore Holdings annual EBITDA year-on-year change?
Over the past year, IMCR annual EBITDA has changed by +$21.76 M (+42.13%)
What is Immunocore Holdings quarterly EBITDA?
The current quarterly EBITDA of IMCR is -$15.27 M
What is the all time high quarterly EBITDA for Immunocore Holdings?
Immunocore Holdings all-time high quarterly EBITDA is $10.91 M
What is Immunocore Holdings quarterly EBITDA year-on-year change?
Over the past year, IMCR quarterly EBITDA has changed by $0.00 (0.00%)
What is Immunocore Holdings TTM EBITDA?
The current TTM EBITDA of IMCR is -$29.57 M
What is the all time high TTM EBITDA for Immunocore Holdings?
Immunocore Holdings all-time high TTM EBITDA is -$29.57 M
What is Immunocore Holdings TTM EBITDA year-on-year change?
Over the past year, IMCR TTM EBITDA has changed by $0.00 (0.00%)